Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, signaling a new build of the page. This update represents a software/version change rather than a modification to the study details or results.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new version of the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe collaborator list now includes Tri-Service General Hospital (TSGH) and the page revision is updated to v3.6.3, replacing the previous Tri-Service General Hospital entry and revision v3.6.2.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's revision history. No study content or data appear to be modified.SummaryDifference0.1%

- Check65 days agoChange DetectedEnrollment status now shows that no participants are being recruited. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Revision: v3.6.0; the Intervention / Treatment heading was reformatted to Intervention/Treatment.SummaryDifference0.4%

- Check72 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 to reflect a newer revision of the page; the change represents an internal metadata update rather than content changes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.